Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs > Eptifibatide for Sale > Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - large image1
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - image1
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - image2
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - image3
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - image4
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99% buy - image5

Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

188627-80-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Packaging:

1G/BAG

Price valid (until):

2026-06-01

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

PEG,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Name:Eptifibatide
    MF:C35H49N11O9S2
    MW:831.97
    CAS:188627-80-7


    Etriptide reverses the binding of fibrinogen, von Willebrand factor, and other adhesives to platelet GPIIb/IIIa receptors by inhibiting platelet aggregation.


    Indicating diseases :Etriptide is used to treat acute coronary syndrome, including unstable angina/non ST segment elevation myocardial infarction, and is suitable for patients undergoing drug therapy or percutaneous coronary intervention (PCI).

    Shop Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%-Detailed Image 1

                                                          ------------------- Company Profile ------------------

    VITALGEN PHARMA CO., LIMITED. is devoted to researching, manufacturing and marketing medical raw materials. The company has established a multi-functional R&D center in Shenzhen Zhongcheng Biomedical Industrial Park, which has a group of innovativedrugs and generic drugs technicians and 60 foreign trade professionals.


    VITALGEN PHARMA CO., LIMITED has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.


      medicine has been highly recognized by many well-known enterprises in the industry and has become their main supplier with high-quality products, honest and pragmatic attitude and good customer service. Tianyuan Medicine is dedicated to provide customers both at home and abroad with advanced technology and reasonable price , Quality products and professional technical services.

    Shop Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%-Detailed Image 2

    Shop Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%-Detailed Image 3

    Shop Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%-Detailed Image 4



    Basic Info
    Product Name:

    Eptifibatide

    Other Name:

    MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2

    CAS No.:

    188627-80-7

    Molecular Formula:

    C35H49N11O9S2

    InChIKeys:

    CZKPOZZJODAYPZ-UHFFFAOYSA-N

    Molecular Weight:

    831.96

    Exact Mass:

    831.315613

    EC Number:

    1312995-182-4

    DSSTox ID:

    DTXSID7046673

    Characteristics
    PSA:

    377 Ų

    XLogP3:

    log Kow = -4.33 (est)

    Density:

    1.6±0.1 g/cm3

    Refractive Index:

    1.735

    Water Solubility:

    In water, 1108 mg/L at 25 °C (est)

    Storage Conditions:

    Eptifibatide should be refrigerated at between 2-8 °C and protected from light until administration.|Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature -20 °C. Store with desiccant. /Eptifibatide acetate/

    Vapor Pressure:

    1.78X10-40 mm Hg at 25 °C (est)

    Henrys Law Constant:

    Henry's Law constant = 9.88X10-34 atm-cu m/mol at 25 °C (est)

    Experimental Properties:

    Hydroxyl radical reaction rate constant = 6.79X10-10 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Specific target organ toxicity – single exposure, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H370 Causes damage to organs

    Precautionary statement(s)
    Prevention

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P308+P316 IF exposed or concerned: Get emergency medical help immediately.

    P321 Specific treatment (see ... on this label).

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    PEG,Semaglutide

    Location:

    1003 SHINGIND BLDG 42-46 TAI LIN PAI RD KWAI CHUNG HONGKONG

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A

    Average lead Time:

    350

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2018

     VITALGEN PHARMA CO., LIMITED is an international leading high-tech enterprise focusing on large-scale biosynthesis of polypeptide drugs. We provide all-round products and services from drug research, clinical development to access to market for global biotechnology and pharmaceutical enterprises.

    We have professional and experienced engineers and scientists, providing new polypeptide drug biosynthesis solutions, which help partners stay ahead of the polypeptide drug discovery, clinical development and market production.
    We have more than 5000 square meters of R&D center and 20000 square meters of intelligent manufacturing base, which can meet the needs of different customers and products, while meeting the GMP conditions for drug production

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Uzbekistan

    Eptifibatide

    60 G Dec 10, 2023
    India

    Eptifibatide

    10 G May 13, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.